The Chemical Fingerprints of Mental Illness
Contd. from part 1
Part 2 of our magazine story on advanced MRI, which is being used to detect unusual levels of signaling molecules in the brains of bipolar patients.
(January 23, 2006) -- Port is one of many researchers now experimenting
with MRI spectroscopy, in which software produces an image of the brain
based on a spectroscopic scan. The image is made up of individual data
points called voxels, cubes analogous to the pixels in a 2-D computer image.
Each corresponds to a volume about the size of a kidney bean. For each voxel,
Port gets a reading on the presence or absence of certain chemicals that are
indicators of brain function.
To understand how MRI spectroscopy works, it's necessary to understand a
bit about how magnetic resonance imaging works more generally. MRI scanners
pick up extremely faint electromagnetic signals coming from protons in the
atoms of molecules that make up the body's tissues -- in this case, brain
tissue.
"Think of it like listening for a pin drop in a thunderstorm," Port says.
Each proton has a magnetic field that points in a certain direction, as the
earth's does. When the MRI is turned on, its magnet aligns the protons'
magnetic fields in the same direction. Bursts of radio frequency energy
temporarily knock some of the protons out of alignment. When the protons
snap back into place, they release energy, generating a minuscule signal
that the MRI's detectors can pick up. By flipping the protons different ways
and measuring various properties of those flips, including the time they
take, researchers can identify various tissues and chemicals in the brain.
Using MRI spectroscopy, Port can measure levels of chemicals such as
n-acetyl aspartate, which is found only in neurons, or glutamate, which
stimulates nerve-cell activity. When Port used the technique across many
areas of the brain in bipolar patients and compared the results to those
from healthy controls, he came up with a chemical fingerprint that seemed to
be an indicator of bipolar disorder.
"When we compared all the bipolar patients in any mood state with their
matched normal control subjects, we found that two areas of the brain were
significantly different," Port says. Port and his team also identified
changes in many regions of the brains of people with bipolar disorder that
indicated whether they were in a
manic state or
depressed. "We found a chemical measure of the mood state," he says.
So has Port found the long-sought diagnostic test for bipolar disorder?
Does his chemical fingerprint reliably identify people who have bipolar
disorder and exclude those who don't?
Maybe, but he can't be sure yet. "We think we're on to something good,"
he says, but "we have to check it and make sure it will be clinically
useful." It's a question of trying the technique with enough patients to be
sure that it is statistically valid -- that it won't produce too many false
positives or false negatives. It doesn't have to be perfect, but it has to
be good enough to add useful information to what psychiatrists can discern
through their traditional methods of diagnosis, interviews, and analyses of
patient histories.
If Port is correct, however, and the technique proves itself, it would be
a landmark in psychiatric research: a diagnostic test for bipolar disorder.
And if the technique works with bipolar disorder, it could be adaptable to
other psychiatric
illnesses.
Port and others are also experimenting with diffusion tensor imaging. DTI
measures water diffusion in the brain. Water flows through the brain as it
does anywhere else -- along the path of least resistance. In the brain,
that's along the axons, the neurons' long tails, which convey electrical
signals to other neurons. (It's from the fatty, white insulation that
surrounds most axons that "white matter" takes its name; the rest of the
neuron, and uninsulated axons, together constitute "gray matter.")
Port is
just beginning to research the technique. But eventually researchers will be
able to use "DTI clinically to look for diseases that interfere with white
matter -- amyotrophic lateral sclerosis [Lou Gehrig's disease] and
schizophrenia," Port says.
Diagnosing Development
The techniques Port is studying, if they prove successful, will be used
in diagnosing people already showing signs of
mental illness.
But what about others who are predisposed to problems but have not yet begun
to exhibit symptoms? Can the MRI technology help to find these people so
that they can be helped before symptoms appear?
Source: MIT Technology Review
Last updated: 1/06
Related Information:
back to
top ~ bipolar news index ~
send page to a
friend |